Recent advancements in Alzheimer's research have unveiled two new drugs and a pioneering blood test, igniting hope among patients. However, their effectiveness and safety raise significant concerns as debates continue over the best treatment approaches.
In a controversial statement, President Trump links Tylenol use during pregnancy to autism development, sparking debate among medical professionals who dispute the claim. Learn more about the FDA's stance and ongoing research.
Pfizer is making headlines with its $7.3 billion acquisition of Metsera, a weight loss drugmaker, as it aims to capture a share of the booming obesity drug market. This deal highlights the growing demand for innovative obesity treatments and Pfizer's strategic pivot following setbacks in its own drug pipeline.
As drugstores gear up to deliver updated COVID-19 vaccines this fall, insurers are set to cover them despite a lack of strong recommendations from health officials. Learn about vaccine availability, coverage details, and eligibility criteria.
In a bold military action, President Trump announced the U.S. military's strike on a vessel from Venezuela allegedly transporting illegal drugs, raising concerns about legality and escalating tensions with cartels.
In Manchester, scientists are divided over the implications of 'mirror life' research, which could lead to synthetic cells with mirror-image molecules. While some see potential benefits, others warn of significant health and environmental risks.
Tensions escalate as Venezuela accuses the U.S. of illegally boarding a fishing boat during a drug search, while U.S. officials deny excessive military actions in the Caribbean.
In a bold move, the Trump administration is sending out 100 cease-and-desist letters to drug companies, aiming to eliminate misleading ads. This crackdown includes increased transparency about drug risks and closing loopholes that conceal vital safety information.
In a groundbreaking move, President Trump has signed a memorandum urging pharmaceutical companies to adhere to transparency laws in their advertising, especially on social media. This initiative aims to ensure accurate drug information and tackle misleading ads, marking a significant shift in health policy.
In a landmark decision, the Trump administration vows to overhaul the regulations on prescription drug advertising. This move aims to ensure consumers receive accurate information about the risks and benefits of medications, combatting misleading ads that favor expensive drugs over affordable generics.
